Palo Alto Investors LP Bluebird Bio, Inc. Transaction History
Palo Alto Investors LP
- $790 Million
- Q2 2024
A detailed history of Palo Alto Investors LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 4,633,351 shares of BLUE stock, worth $2.18 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
4,633,351
Previous 4,560,171
1.6%
Holding current value
$2.18 Million
Previous $5.84 Million
22.22%
% of portfolio
0.57%
Previous 0.68%
Shares
3 transactions
Others Institutions Holding BLUE
# of Institutions
162Shares Held
79.9MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$7.26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$4.84 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.42 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$2.19 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $36.2M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...